Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. Pylori Eradication for Gastric Polyp Regression
NCT03065868Phase 4Completed
- Sponsor
- Kyungpook National University Hospital
- Start
- Dec 2015
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin, lansoprazole and clarithromycin in Helicobacter pylori infection (2 arms), sponsored by Kyungpook National University Hospital. Primary endpoint: Regression rate of gastric polyps at 24 months. Started Dec 2015; status: completed.
02
Drugs
amoxicillinlansoprazoleclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03065868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03065868.